TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.

[1]  E. Romagnoli,et al.  Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. , 2012, Journal of the American College of Cardiology.

[2]  A. Shimony,et al.  Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. , 2012, The American journal of cardiology.

[3]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[4]  G. Levine,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Journal of the American College of Cardiology.

[5]  Laura Mauri,et al.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.

[6]  J. Aronson,et al.  Stephens' detection and evaluation of adverse drug reactions : principles and practice , 2011 .

[7]  John J. Graham,et al.  Characterization of Operator Learning Curve for Transradial Coronary Interventions , 2011, Circulation. Cardiovascular interventions.

[8]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[9]  Changchun Xie,et al.  Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. , 2011, JACC. Cardiovascular interventions.

[10]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[11]  Sunil V. Rao,et al.  Incidence, prognostic impact, and influence of antithrombotic therapy on access and nonaccess site bleeding in percutaneous coronary intervention. , 2011, JACC. Cardiovascular interventions.

[12]  M. Pencina,et al.  Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent , 2010, American heart journal.

[13]  Scott R Kegler,et al.  National estimates of emergency department visits for hemorrhage-related adverse events from clopidogrel plus aspirin and from warfarin. , 2010, Archives of internal medicine.

[14]  S. Pocock,et al.  A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[15]  John A Spertus,et al.  Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention. , 2010, JAMA.

[16]  Sunil V. Rao,et al.  The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. , 2010, Journal of the American College of Cardiology.

[17]  H. Gurm,et al.  Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry. , 2010, American heart journal.

[18]  I. Ungi,et al.  Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction Systematic overview and meta-analysis. , 2009, American heart journal.

[19]  T. Ryan,et al.  Significantly Improved Vascular Complications Among Women Undergoing Percutaneous Coronary Intervention: A Report From the Northern New England Percutaneous Coronary Intervention Registry , 2009, Circulation. Cardiovascular interventions.

[20]  Jean-Pierre Valentin,et al.  Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative. , 2009, American heart journal.

[21]  D. Holmes,et al.  Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. , 2009, Journal of the American College of Cardiology.

[22]  K. Alexander,et al.  Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial). , 2009, The American journal of cardiology.

[23]  P. Poirier,et al.  Impact of female gender and transradial coronary stenting with maximal antiplatelet therapy on bleeding and ischemic outcomes. , 2009, American heart journal.

[24]  S. Pancholy,et al.  Prevention of radial artery occlusion—Patent hemostasis evaluation trial (PROPHET study): A randomized comparison of traditional versus patency documented hemostasis after transradial catheterization , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[25]  Fang-Shu Ou,et al.  Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[26]  J D Hilton,et al.  Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) , 2008, Heart.

[27]  A. Kastrati,et al.  Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. , 2008, Journal of the American College of Cardiology.

[28]  H. White,et al.  Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. , 2007, Journal of the American College of Cardiology.

[29]  K. Alexander,et al.  Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors: Results From the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines) Initiative , 2006, Circulation.

[30]  V. Vaccarino,et al.  Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. , 2006, The American journal of cardiology.

[31]  R. Brindis,et al.  Risk of local adverse events following cardiac catheterization by hemostasis device use - phase II. , 2005, The Journal of invasive cardiology.

[32]  R. Califf,et al.  Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. , 2005, The American journal of cardiology.

[33]  L. Pilote,et al.  Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. , 2005, Archives of internal medicine.

[34]  G. Biondi-Zoccai,et al.  Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials. , 2004, Journal of the American College of Cardiology.

[35]  A. Schmermund,et al.  Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. , 2004, The Journal of invasive cardiology.

[36]  N. Weissman,et al.  Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. , 2003, The American journal of cardiology.

[37]  E. Topol,et al.  Practice patterns and outcomes of percutaneous coronary interventions in the United States: 1995 to 1997. , 2002, The American journal of cardiology.

[38]  K. Anstrom,et al.  Effect of gender on the outcomes of contemporary percutaneous coronary intervention. , 2001, The American journal of cardiology.

[39]  M. Morice,et al.  Coronary angiography through the radial or the femoral approach: The CARAFE study , 2001, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[40]  K. Hornbuckle,et al.  Evaluation of the Characteristics of Safety Withdrawal of Prescription Drugs from Worldwide Pharmaceutical Markets-1960 to 1999 , 2001 .

[41]  K. Anstrom,et al.  Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.

[42]  D. Cohen,et al.  Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison. , 1999, American heart journal.

[43]  M. Morice,et al.  Radial approach: what about the learning curve? , 1997, Catheterization and cardiovascular diagnosis.

[44]  M. Leon,et al.  Vascular Complications After Balloon and New Device Angioplasty , 1993, Circulation.

[45]  B. Gersh.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2012 .

[46]  G. Montalescot,et al.  Bleeding complications in primary percutaneous coronary intervention of ST‐elevation myocardial infarction in a radial center , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[47]  M. Turakhia,et al.  Developing the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium "Incubator" Think Tank. , 2010, American heart journal.

[48]  D. Mark,et al.  Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank. , 2010, American heart journal.

[49]  Salim Yusuf,et al.  Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. , 2009, American heart journal.

[50]  R. Brindis,et al.  Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. , 2004, The Journal of invasive cardiology.

[51]  Innovation OR Stagnation.  Challenge and Opportunity on the Critical Path to New Medical Products , 2004 .